Domov › Nemalicelični pljučni rak › Washington › Tacoma

Klinične študije za Nemalicelični pljučni rak v Tacoma, WA

20 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Tacoma in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2

Northwest Medical Specialties Tacoma /ID# 270534, Tacoma

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06568939

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Vključevanje udeležencevFaza 1/2

Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
Vista Oncology - East Olympia /ID# 275438, Olympia · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT06772623

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Vključevanje udeležencevFaza 3

Northwest Medical Specialties - Tacoma, Tacoma
Northwest Medical Specialties - Gig Harbor, Gig Harbor · 8 mi stran
Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · 8 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06472245

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 3

American Oncology Network Vista Oncology Division-West office, Olympia · 26 mi stran
American Oncology Network Vista Oncology Division-East office, Olympia · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07144280

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Vključevanje udeležencevFaza 3

Vista Oncology Inc PS, Olympia · 26 mi stran

Starost 18–100 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05920356

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2

Vista Oncology, Olympia · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06667076

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Vključevanje udeležencevFaza 3

American Oncology Network Vista Oncology Division-West office, Olympia · 26 mi stran
American Oncology Network Vista Oncology Division-East office, Olympia · 26 mi stran

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06758401